These Patients Have Nothing Else. Should That Be Enough for FDA Drug Approval?
Despite Streamlined Processes, FDA’s Role in Rare-Disease Drug Development Draws Continued Scrutiny
Despite Streamlined Processes, FDA’s Role in Rare-Disease Drug Development Draws Continued Scrutiny
LDI Fellows Used Medicaid Data to Identify Individuals at Highest Risk for Cocaine- and Methamphetamine-Related Overdoses, Paving the Way for Targeted Prevention
More Focused and Comprehensive Large Language Model Chatbots Envisioned
Medicare Advantage Modestly Cut Black–White Disparities in Chronic Disease Prevention Compared to Traditional Medicare, but Care Gaps Remain for Latinx Populations
How Threatened Reproductive Rights Pushed More Pennsylvanians Toward Sterilization
Billing Codes That Flag Food, Job, or Housing Insecurity in Medical Records are Underused for the Sickest Medicare Patients
Promising New Evidence and What’s Next
Precision Diagnostics Give Patients Clearer Answers About What Drives Cognitive Impairment
Abortion Restrictions Can Backfire, Pushing Families to End Pregnancies
With Drastic Cuts on the Table, What’s the Best Way To Fund Medical Innovation – NIH Grants, Prizes, or Bold New Models?
An Analysis of Penn Medicine Healthy Heart Program Provides Insights
From 1990 to 2019, Black Life Expectancy Rose Most in Major Metros and the Northeast—but Gains Stalled or Reversed in Rural Areas and the Midwest, Especially for Younger Adults